The next generation of biotechnology
bridging advanced computational design with precise chemical synthesis to address critical unmet needs in therapeutics. As a privately held company, we collaborate closely with leading university researchers and professors to accelerate innovative drug candidates from concept through preclinical validation.
- Drug Design & Optimization
- Chemical Composition Analysis
- Synthesis & Process
- Preclinical Evaluation
- Product Safety & Efficacy Analysis
- Pipeline Progression
- Collaborative Efficiency
- Partnership Approach
-
Innovative R&D Solutions
-
Microbiological Testing
-
Environmental Testing
-
Pharmaceutical Research
-
Biotechnology Innovations
-
Water & Air Quality Testing
-
Innovative R&D Solutions
-
Microbiological Testing
-
Environmental Testing
-
Pharmaceutical Research
-
Biotechnology Innovations
-
Water & Air Quality Testing
Comprehensive Analog Compound Discovery & Preclinical Capabilities
Molecular Design & Computational Modeling
Ausovi engineers novel analog compounds using advanced computational tools and structure-based design to optimize specificity and therapeutic potential.
Chemical Synthesis & Process Development
Precision organic synthesis and scalable production methods create high-purity analogs, supported by proprietary routes and optimization protocols.
Analytical Characterization
State-of-the-art instrumentation (NMR, LC-MS, HPLC) ensures structural confirmation, purity assessment, and detailed compound profiling.
Preclinical In Vitro & In Vivo Evaluation
Rigorous biological assays and access to advanced models validate efficacy, safety, pharmacokinetics, and mechanism of action.
Academic & Institutional Collaborations
Strategic partnerships with leading universities (e.g., UCSD, Saint Joseph’s) provide specialized expertise, facilities, and accelerated validation.
Intellectual Property & Portfolio Building
Layered patent strategies protect compositions, methods, and processes, integrating successful candidates into our growing portfolio of innovative therapeutics.